Success with droplet-based microfluidics

Sundar Hengoju in the laboratory
Sundar Hengoju in the laboratory. Source: Anna Schroll / Leibniz-HKI

We congratulate Sundar Hengoju on the best presentation by a young scientist at the “Leibniz Conference on Bioactive Compounds”. He won over the jury with his report on “Advancements in antibiotic discovery using droplet microfluidics and multiplexed reporter strains for high-throughput screening”.

The “Leibniz Conference on Bioactive Compounds” of the Leibniz Research Network on Active Compounds took place this year on April 24 and 25 at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena. A total of 70 scientists from all over the world met in the Thuringian research metropolis. The keynote speakers included Fabrizio D'Adda Di Fagagna from the Institute of Molecular Oncology in Milan and Jan Krönke from the Charité in Berlin.

In addition to the professional exchange, the programme also included award ceremonies. This year, the “Leibniz Drug of the Year 2024” award went to Yvonne Mast's team from the Leibniz Institute DSMZ. The group received the award for their findings on biotransformation-coupled mutasynthesis to generate novel pristinamycin derivatives. This year's Research Award was presented to Professor Krönke from the Department of Haematology, Oncology and Tumour Immunology at Charité Universitätsmedizin Berlin. He is one of the pioneers of PROTAC research. In particular, he has made a significant contribution to clarifying the role of thalidomide and ubiquitin ligases as well as blood cancer in general. The usual mitosis inhibitors are often ineffective against this.

Young scientists also have the opportunity to draw attention to themselves. Dr Sundar Hengjou, scientific coworker at the Leibniz-HKI's Bio Pilot Plant, received the prize for the best young scientist´s talk. He impressed the jury with his results on the search for new antibiotics using droplet-based microfluidics.

Further information:


Sundar Hengoju